Biochemics Inc Headquarters
Looking for information about Biochemics Inc Headquarters? The links below have collected all the necessary data.
https://www.crunchbase.com/organization/biochemics-inc
BioChemics Inc is a Health Care company. Danvers, Massachusetts, United States. 11-50. Private. biochemics.com. 554,656.Occupation: CEO & Chairman
http://www.businesswire.com/news/home/20080411005014/en/Company-Profile-BioChemics
Apr 11, 2008 · BioChemics, Inc Headquarters Address: 99 Rosewood Drive Danvers, MA Main Telephone: 978.750.0090 Website: www.biochemics.com Type of Organization:
https://www.bloomberg.com/profile/company/0282846D:US
99 Rosewood Drive #270 Danvers, MA 01923 United States. PHONE. 1-978-750-0090. WEBSITE. www.biochemics.com. NO. OF EMPLOYEES. --. Board Members.Employees: 14
https://pitchbook.com/profiles/company/62590-87
EUROPEAN Headquarters +44 (0) 20 8037.2308; 1st Floor Saffron House; 6-10 Kirby Street; London EC1N 8TS; United Kingdom
https://www.plainsite.org/profiles/biochemics-inc/
Biochemics, Inc.'s PlainSite profile, including litigation, intellectual property, public records and more. Biochemics, Inc.'s PlainSite profile, including litigation, intellectual property, public records and more. Biochemics, Inc. United States C Corporation. No tags have been applied so far. Sign in to add some.
https://stephencataldo.com/Vaso/index.html
Mar 25, 2008 · Welcome to BioChemics! Headquartered in Danvers, Massachusetts, BioChemics Inc., is a specialty pharmaceutical company that has developed a novel, transdermal drug delivery system for the first time that may allow almost any drug to be efficiently delivered through the skin. The transdermal technology, called VALE® (Vaso-active Lipid Encapsulated), may allow a substantial portion of the pharmacopeia to be …
https://www.topionetworks.com/companies/inpellis-564af924b6e9f4db5600048e
Inpellis is a specialty pharmaceutical company developing transdermal product candidates for treating pain resulting from musculoskeletal disorders and peripheral neuropathy. Inpellis has acquired from BioChemics, Inc. (“BioChemics”) full or joint ownership of transdermal formulations which utilize the endel™ (vasoactive lipid encapsulated) transdermal drug delivery system for non-dermal ...
Have you found Biochemics Inc Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.
Related Pages:
|
Recently Added Pages:
|